Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We investigated the association of ANGPTL4, one of the HIF1-α transcription factors, with head and neck cancer. We examined the immunohistological expression of ANGPTL4 in hypopharyngeal carcinoma cases and its association with clinical data. Multivariate analysis revealed that ANGPTL4 expression was an independent prognostic determinant for overall survival. Similar results were obtained for oropharyngeal carcinoma patients. Subsequent knockdown of ANGPTL4 expression in head and neck cancer cell lines showed that the down-regulation of ANGPTL4 reduced the expression of EMT-associated genes and genes associated with cancer stem cell properties. These results indicated that ANGPTL4 has a possibility to act as a tumor suppressor in head and neck cancers, although ANGPTL4 has been reported to be involved in both tumor promotion and suppression.
|